- Report
- January 2024
- 91 Pages
Global
From €3500EUR$3,923USD£3,082GBP
- Report
- May 2024
- 50 Pages
Global
From €2532EUR$2,650USD£2,155GBP
- Report
- May 2024
- 50 Pages
Global
From €2532EUR$2,650USD£2,155GBP
- Report
- July 2022
- 220 Pages
Global
From €3412EUR$3,570USD£2,903GBP
- Report
- April 2024
- 160 Pages
Global
From €5733EUR$5,999USD£4,878GBP
Aripiprazole is a medication used to treat mental disorders such as schizophrenia, bipolar disorder, and major depressive disorder. It is a dopamine partial agonist, meaning it works by stimulating dopamine receptors in the brain. Aripiprazole is also used to treat irritability and symptoms associated with autism spectrum disorder. It is available in both oral and injectable forms.
Aripiprazole is generally well-tolerated and has fewer side effects than other antipsychotic medications. It is also less likely to cause weight gain and metabolic changes than other antipsychotics.
The aripiprazole market is highly competitive, with many companies offering generic versions of the drug. Companies such as Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals are some of the major players in the market. Other companies such as Dr. Reddy's Laboratories, Lupin, and Torrent Pharmaceuticals also offer generic versions of the drug. Show Less Read more